Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma.
Li Z, Ju X, Lee K, Clarke C, Hsu JL, Abadir E, Bryant CE, Pears S, Sunderland N, Heffernan S, Hennessy A, Lo TH, Pietersz GA, Kupresanin F, Fromm PD, Silveira PA, Tsonis C, Cooper WA, Cunningham I, Brown C, Clark GJ, Hart DNJ. Li Z, et al. Among authors: cooper wa. Haematologica. 2018 Apr;103(4):655-665. doi: 10.3324/haematol.2017.178384. Epub 2018 Jan 19. Haematologica. 2018. PMID: 29351987 Free PMC article.
Targeting CD83 in mantle cell lymphoma with anti-human CD83 antibody.
Li Z, Abadir E, Lee K, Clarke C, Bryant CE, Cooper W, Pietersz G, Favaloro J, Silveira PA, Nj Hart D, Ju X, Clark GJ. Li Z, et al. Clin Transl Immunology. 2020 Jul 15;9(7):e1156. doi: 10.1002/cti2.1156. eCollection 2020. Clin Transl Immunology. 2020. PMID: 32685149 Free PMC article.
Fluorescent In Situ Hybridization in Surgical Pathology Practice.
Gupta R, Cooper WA, Selinger C, Mahar A, Anderson L, Buckland ME, O'Toole SA. Gupta R, et al. Among authors: cooper wa. Adv Anat Pathol. 2018 Jul;25(4):223-237. doi: 10.1097/PAP.0000000000000194. Adv Anat Pathol. 2018. PMID: 29727321 Review.
Clinical Utility of In Situ Hybridization Assays in Head and Neck Neoplasms.
Luk PP, Selinger CI, Cooper WA, Mahar A, Palme CE, O'Toole SA, Clark JR, Gupta R. Luk PP, et al. Among authors: cooper wa. Head Neck Pathol. 2019 Sep;13(3):397-414. doi: 10.1007/s12105-018-0988-1. Epub 2018 Nov 22. Head Neck Pathol. 2019. PMID: 30467669 Free PMC article. Review.
Relationship between PD-L1 expression and outcome in EGFR-mutant lung cancer patients treated with EGFR tyrosine kinase inhibitors.
Liu J, Itchins M, Nagrial A, Cooper WA, De Silva M, Barnet M, Varikatt W, Sivasubramaniam V, Davis A, Gill AJ, Blinman P, Lee K, Hui R, Gao B, Pavlakis N, Clarke S, Lee J, Boyer M, Kao S. Liu J, et al. Among authors: cooper wa. Lung Cancer. 2021 May;155:28-33. doi: 10.1016/j.lungcan.2021.03.004. Epub 2021 Mar 9. Lung Cancer. 2021. PMID: 33721613
230 results